Search Results

There are 2359 results for: content related to: The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children

  1. You have free access to this content
    Omalizumab for asthma in adults and children

    Intervention Review

    The Cochrane Library

    Rebecca Normansell, Samantha Walker, Stephen J Milan, E. Haydn Walters and Parameswaran Nair

    Published Online : 13 JAN 2014, DOI: 10.1002/14651858.CD003559.pub4

  2. Anti-IgE in Persistent Severe Allergic Asthma

    Allergy and Allergic Diseases, Volume 1, Second Edition

    Marc Humbert, Stephen T. Holgate, Howard Fox, Jean Bousquet, Pages: 1661–1686, 2009

    Published Online : 10 FEB 2009, DOI: 10.1002/9781444300918.ch81

  3. You have free access to this content
    EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders

    Allergy

    Volume 70, Issue 7, July 2015, Pages: 727–754, O. Boyman, C. Kaegi, M. Akdis, S. Bavbek, A. Bossios, A. Chatzipetrou, T. Eiwegger, D. Firinu, T. Harr, E. Knol, A. Matucci, O. Palomares, C. Schmidt-Weber, H.-U. Simon, U. C. Steiner, A. Vultaggio, C. A. Akdis and F. Spertini

    Version of Record online : 24 APR 2015, DOI: 10.1111/all.12616

  4. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy

    Clinical & Experimental Allergy

    Volume 35, Issue 4, April 2005, Pages: 408–416, S. T. Holgate, R. Djukanović, T. Casale and J. Bousquet

    Version of Record online : 11 APR 2005, DOI: 10.1111/j.1365-2222.2005.02191.x

  5. You have free access to this content
    Role of immunmodulators in allergen-specific immunotherapy

    Allergy

    Volume 66, Issue 6, June 2011, Pages: 792–797, M. V. Kopp

    Version of Record online : 18 FEB 2011, DOI: 10.1111/j.1398-9995.2011.02553.x

  6. Omalizumab (Xolair): Anti-Immunoglobulin E Treatment in Allergic Diseases

    Handbook of Therapeutic Antibodies

    Claus Kroegel, Martin Foerster, Pages: 951–997, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch37

  7. Safety and tolerability of omalizumab

    Clinical & Experimental Allergy

    Volume 39, Issue 6, June 2009, Pages: 788–797, J. Corren, T. B. Casale, B. Lanier, R. Buhl, S. Holgate and P. Jimenez

    Version of Record online : 17 MAR 2009, DOI: 10.1111/j.1365-2222.2009.03214.x

  8. You have free access to this content
    Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria

    Journal of the European Academy of Dermatology and Venereology

    Volume 30, Issue S5, July 2016, Pages: 25–32, A. M. Giménez-Arnau, E. Toubi, A. M. Marsland and M. Maurer

    Version of Record online : 10 JUN 2016, DOI: 10.1111/jdv.13697

  9. You have free access to this content
    An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma

    Allergy

    Volume 63, Issue 6, June 2008, Pages: 670–684, S. D. Sullivan and F. Turk

    Version of Record online : 25 APR 2008, DOI: 10.1111/j.1398-9995.2008.01723.x

  10. Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment

    British Journal of Dermatology

    Volume 173, Issue 2, August 2015, Pages: 404–415, M.C. Urgert, M.T. van den Elzen, A.C. Knulst, Z. Fedorowicz and E.J. van Zuuren

    Version of Record online : 22 JUL 2015, DOI: 10.1111/bjd.13845

  11. You have free access to this content
    Management and treatment of chronic urticaria (CU)

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue S3, June 2015, Pages: 16–32, M. Maurer, M.K. Church, M. Gonçalo, G. Sussman and M. Sánchez-Borges

    Version of Record online : 4 JUN 2015, DOI: 10.1111/jdv.13198

  12. Omalizumab may not inhibit mast cell and basophil activation in vitro

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 9, September 2015, Pages: 1832–1836, J. Gericke, T. Ohanyan, M.K. Church, M. Maurer and M. Metz

    Version of Record online : 26 SEP 2014, DOI: 10.1111/jdv.12693

  13. Immunoglobulin E Blockade in the Treatment of Asthma

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 10, October 2007, Pages: 1412–1424, Robert Kuhn

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.10.1412

  14. Impact of omalizumab on medical cost of childhood asthma in Japan

    Pediatrics International

    Volume 58, Issue 5, May 2016, Pages: 425–428, Hideki Yoshikawa, Mihoko Iwata, Hiroshi Matsuzaki, Rintaro Ono, Yoko Murakami, Naohiko Taba, Satoshi Honjo, Chikako Motomura and Hiroshi Odajima

    Version of Record online : 13 MAY 2016, DOI: 10.1111/ped.12936

  15. You have free access to this content
    Effects of omalizumab on markers of inflammation in patients with allergic asthma

    Allergy

    Volume 64, Issue 12, December 2009, Pages: 1728–1736, S. Holgate, N. Smith, M. Massanari and P. Jimenez

    Version of Record online : 15 OCT 2009, DOI: 10.1111/j.1398-9995.2009.02201.x

  16. You have free access to this content
    Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE

    British Journal of Clinical Pharmacology

    Volume 72, Issue 2, August 2011, Pages: 306–320, Philip J. Lowe and Didier Renard

    Version of Record online : 11 JUL 2011, DOI: 10.1111/j.1365-2125.2011.03962.x

  17. You have free access to this content
    The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective

    Allergy

    Volume 65, Issue 9, September 2010, Pages: 1141–1148, J. D. Campbell, D. E. Spackman and S. D. Sullivan

    Version of Record online : 10 FEB 2010, DOI: 10.1111/j.1398-9995.2010.02336.x

  18. You have free access to this content
    Poster Discussion Session PDS 1

    Allergy

    Volume 71, Issue S102, August 2016, Pages: 118–272,

    Version of Record online : 19 AUG 2016, DOI: 10.1111/all.12972

  19. You have full text access to this OnlineOpen article
    Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment

    Allergy

    Volume 71, Issue 9, September 2016, Pages: 1335–1344, A. Magnan, A. Bourdin, C. M. Prazma, F. C. Albers, R. G. Price, S. W. Yancey and H. Ortega

    Version of Record online : 24 MAY 2016, DOI: 10.1111/all.12914

  20. You have free access to this content
    ‘Real-life’ effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review

    Allergy

    Volume 71, Issue 5, May 2016, Pages: 593–610, I. Abraham, A. Alhossan, C. S. Lee, H. Kutbi and K. MacDonald

    Version of Record online : 25 FEB 2016, DOI: 10.1111/all.12815